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Mitochondrial dysfunction has long been implicated in the
etiopathogenesis of Parkinson's disease (PD), based on the observa-
tion that mitochondrial toxins can cause parkinsonism in humans and
animal models. Research into the function and dysfunction of PD-
associated genes revealed that at least some of these genes interface
with pathways regulating various aspects of mitochondrial biology.
Mutations in the parkin gene, encoding an E3 ubiquitin ligase, are
responsible for the majority of autosomal recessive parkinsonism.
Our previous work revealed that parkin is a stress-inducible protein
with a wide neuroprotective capacity, preventing cell death under
various stress conditions. We now present evidence that the acute
stress-protective activity of parkin and its capacity to induce
mitophagy are mediated by two separate and independent pathways.
While a functional autophagic machinery and expression of the
mitochondrial kinase PINK1 is required for parkin-induced mitophagy,
these components are dispensable for the anti-apoptotic activity of
parkin. We identiﬁed a signaling pathway that is essential for the anti-
apoptotic activity of parkin but not for induction of mitophagy. In
support of this concept, parkin seems to exert adaptive effects on
mitochondria depending on the severity of mitochondrial damage.
Parkin prevents stress-induced cell death under moderate stress
conditions with only minor mitochondrial defects. However, when
mitochondria are irreversibly damaged in response to severe stress,
parkin can promote their elimination via mitophagy.
doi:10.1016/j.bbabio.2012.06.212
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Mutations in PTEN-induced putative kinase 1 (PINK1) cause a
recessive form of Parkinson's disease (PD). PINK1 is associated with
mitochondrial quality control and its partial knock-down induces
mitochondrial dysfunction including decreased membrane potential
and increased vulnerability against mitochondrial toxins, but the
exact function of PINK1 in mitochondria has not been investigated
using cells with null expression of PINK1. Here, we show that loss of
PINK1 causedmitochondrial dysfunction. In PINK1-deﬁcient (PINK1−/−)
mouse embryonicﬁbroblasts (MEFs),mitochondrialmembrane potential
and cellular ATP levelswere decreased comparedwith those in littermate
wild-type MEFs. However, mitochondrial proton leak, which reduces
membrane potential in the absence of ATP synthesis, was not altered by
loss of PINK1. Instead, activity of the respiratory chain, which produces
the membrane potential by oxidizing substrates using oxygen, declined.
H2O2 production rate by PINK1−/− mitochondria was lower than
PINK1+/+ mitochondria as a consequence of decreased oxygen
consumption rate, while the proportion (H2O2 production rate per
oxygen consumption rate) was higher. These results suggest that
mitochondrial dysfunctions in PD pathogenesis are caused not by
proton leak, but by respiratory chain defects.
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The selective loss of neural cells from a particular brain region is a
common feature of neurodegenerative diseases. A failure of mito-
chondrial function seems to be a causative factor. Hypoxia [1,2] and
toxins, such as 3-nitropropionic acid (3-NPA, [3–5]) and 1-methyl-4-
phenylpyridinium (MPP+ [6,7]), affect mitochondrial function as well
as neural cell viability and are known as inducers of stroke,
Huntington's and Parkinson's disease, respectively.
We demonstrated that hypoxia and these neurotoxins affect
mitochondrial gene expression, ATP and reactive oxygen species
(ROS) production and that cytochrome c oxidase (COX), the terminal
enzyme of the mitochondrial respiratory chain, appears to play a
crucial role. The application of hypoxia [1,2], 3-NPA [3–5] and MPP+
[6,7] to cultured primary astrocytes and neurons from different brain
regions of female and male mice caused an increase of COX isoform
IV-2 transcription and protein expression in neural cells from cortex
(hypoxia), female/male striatum (3-NPA) andmalemidbrain (MPP+).
A siRNA against COX IV-2 revealed that COX IV-2 is causally related
to elevated intracellular ATP levels at the expense of increased mito-
chondrial ROS production and neural cell death.
Our data suggest that cell death in response to hypoxia, 3-NPA and
MPP+ is primarily caused due to increased oxidative stress in neural
cells in a brain region-speciﬁc and in case of MPP+ also in a gender-
speciﬁc way. COX appears to take center stage of metabolic and cell
survival control in stroke and neurodegeneration [8].
This work was supported by DFG (AR343/4-1).
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Hypoxia leads to a massive release of neurotransmitter glutamate
resulting in overactivation of glutamate receptors during ischemic
stroke. These processes are usually accompanied by elevation of
hydrogen peroxide and nitric oxide generation which causes mito-
chondrial permeability transition and suppresses oxidative phosphor-
ylation. Meanwhile, it is possible to assume that a direct signaling
pathway linked hypoxia and mitochondria. Our aim was to study the
main biochemical mechanisms realized in mitochondria during
oxidation stress under hypoxia/reoxygenation conditions.
We used a model of mitochondria isolated from rat brain using
Percoll density centrifugation surviving under hypoxia. After 10 min
of incubation under hypoxic conditionsmitochondrial respiratory control
index (RCI) was reduced by 40%. This reduction of RCI was accompanied
by increased H2O2 generation. It was found that if the incubation of
mitochondria was carried out in the presence of glycine 5 mM and
MK-801 10 μM (an inhibitor of glutamate receptors), reduction of RCI
and increase of H2O2 generation was signiﬁcantly lower.
Whereas hypoxia causes elevation of glutamate concentration we
made a pioneering hypothesis that glutamate could activate signaling
processes in mitochondria by itself. Indeed a very low dose of
glutamate (5–50 μM) added to isolated mitochondria in the presence
of rotenone (inhibitor of complex I mitochondrial respiratory chain)
stimulates the generation of H2O2 up to 4 fold in a dose-dependent
manner. The process was signiﬁcantly reduced by MK-801 10 μM and
glycine 5 mM. These results suggest the possible existence of a
glutamate receptor in brain mitochondria.
Our ﬁndings suggest a novel mechanism by which brain
mitochondria could directly sense the signal of an elevated glutamate
level under hypoxia.
doi:10.1016/j.bbabio.2012.06.215
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The study was designed to investigate the beneﬁcial effect of
quercetin supplementation on rat brain mitochondrial bioenergetics,
oxidative stress and neurobehavioral impairments observed in a 3-
nitropropionic acid (3-NP) induced rodent model of Huntington's
disease (HD). A single oral dose of quercetin was supplemented to the
animals through gavage 1 h prior to 3-NP administration. However, a
sub-chronic dose of 3-NP was administered twice daily. On day 21,
after behavioral observation was recorded in all four groups, animals
were sacriﬁced and striatal mitochondrial fractions were obtained for
analyzing beneﬁcial effects of quercetin on several parameters such
as respiratory chain complexes including mitochondrial swelling,
antioxidative enzyme proﬁle, neurobehavioral deﬁcits and histopath-
ological changes. Quercetin supplemented animals showed a signif-
icant improvement of respiratory chain complexes accompanied by
decreased mitochondrial swelling, resulting in decreased generation
of mitochondrial oxidative stress in terms of lowered levels of lipid
peroxidation, improved functioning of superoxide dismutase, catalase
and thiol levels in comparison to 3-NP induced HD animals. Improved
neurobehavioral abilities following quercetin supplementation were
also observed on behavioral tasks (narrow beamwalk, actophotometer
and gait analysis) given to the animals. Also, histopathological features
in striatal tissue showed less or absent pyknotic nuclei and astrogliosis
in quercetin supplemented animals as compared to 3-NP administered
animals. Altogether, our results show that quercetin supplementation
to 3-NP induced HD animals ameliorated mitochondrial dysfunctions,
mitochondrial oxidative stress and neurobehavioral deﬁcits, showing
the capability of this ﬂavonoid in improving mitochondrial functions,
suggesting a putative role of quercetin in HD management.
doi:10.1016/j.bbabio.2012.06.216
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Lysosomal storage disorders are a group of rare inherited
metabolic disorders, of which, Gaucher disease (GD) is the most
common. GD is caused by mutations in the glucocerebrosidase (GBA)
gene. A loss of functional GBA in the lysosomes leads to accumulation
of glucocerebroside, resulting in non-functional organelles. This has
far reaching implications in the autophagy process, where lysosomes
fuse with autophagosomes to degrade unwanted or damaged cellular
material. Strong evidence has emerged linking lysosomal dysfunction
and Parkinson's disease (PD); individuals with a heterozygous
mutation in GBA have a ﬁve fold increased risk of developing PD
and those with a homozygous loss of GBA have up to a twenty fold
increased risk. Individuals with loss of GBA activity have the highest
genetic predisposition to developing PD.
Using amurinemodel of type II neuropathic GD, primary neurons and
astrocytes from gba−/− mice have reduced mitochondrial membrane
potential and hydrolyse ATP in order to maintain it. This reduction in
membrane potential coincides with mitochondrial fragmentation
in neurons and astrocytes due to increased OPA1 processing. This
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